Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-SMART
NCT07457333Phase 2Enrolling by invitation
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Feb 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Beta-sitosterol in subarachnoid hemorrhage (SAH), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Feb 2026; status: enrolling by invitation.
02
Drugs
Beta-sitosterol
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT07457333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07457333.